Hudie Wei

2.2k citations
31 papers · 1.5k indexed · 2 hit papers · h-index 14
Topics
Fibroblast Growth Factor Research (5 papers)RNA Interference and Gene Delivery (5 papers)Cell death mechanisms and regulation (5 papers)

In The Last Decade

Hudie Wei

29 papers receiving 1.5k citations

Hit Papers

Targeting p53 pathways: mechanisms, structures and a...202120262022202420232021100200300400

Peers

Hudie Wei
Comparison fields: 5 of 102
  • Molecular Biology 835
  • Oncology 550
  • Cancer Research 220
  • Immunology 211
  • Epidemiology 166
Replace Lan Wang with:
Lan Wang China
Lijun Di China
Justin M. Drake United States
Svetlana Bergelson United States
Niklas K. Finnberg United States
Sven A. Lang Germany
Xu Liu China
An Wouters Belgium
Takeshi Iwamura Japan
Hwang‐Phill Kim South Korea
Hudie Wei relative to Lan Wang China Lan Wang's profile →
Citations per field
00.5×
Lan Wang · 1×
Citations per year

Countries citing papers authored by Hudie Wei

Since Specialization
Citations

This map shows the geographic impact of Hudie Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hudie Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hudie Wei more than expected).

Fields of papers citing papers by Hudie Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hudie Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hudie Wei. The network helps show where Hudie Wei may publish in the future.

Co-authorship network of co-authors of Hudie Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Hudie Wei. A scholar is included among the top collaborators of Hudie Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hudie Wei. Hudie Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 6
4 2
5 4
6 58
7 5
8 17
9 5
10 7
11 37
12 10
13 13
14 76
15 208
16
Farnesoid X receptor (FXR): Structures and ligandsbreakdown →
163
17 18
18 25
19 7
20 9

About Hudie Wei

Hudie Wei is a scholar working on Hepatology, Oncology and Toxicology, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (5 papers), RNA Interference and Gene Delivery (5 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Oncology (550 citations), Cancer Research (220 citations) and Molecular Biology (835 citations). Hudie Wei has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yongheng Chen, Haolan Wang, Ming Guo, Ming Guo, Longying Jiang, Shuyan Dai, Desheng Xiao, Lingzhi Qu, Huajun Zhang and Zhuchu Chen. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026